CoChat
Sign Up
Cited by 404Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsNanoparticles: synthesis and applications

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles

Open access
Arvizo, Rochelle R., Miranda, Oscar R., Moyano, Daniel F., Walden, Chad A., Giri, Karuna, Bhattacharya, Resham, Robertson, J. David, Rotello, Vincent M., Reid, Joel M., Mukherjee, Priyabrata·2011·PLoS ONE
DOI 10.1371/journal.pone.0024374PMC PMC3172229
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: Inorganic nanoparticles provide promising tools for biomedical applications including detection, diagnosis and therapy. While surface properties such as charge are expected to play an important role in their in vivo behavior, very little is known how the surface chemistry of nanoparticles influences their pharmacokinetics, tumor uptake, and biodistribution. METHOD/PRINCIPAL FINDINGS: Using a family of structurally homologous nanoparticles we have investigated how pharmacological properties including tumor uptake and biodistribution are influenced by surface charge using neutral (TEGOH), zwitterionic (Tzwit), negative (TCOOH) and positive (TTMA) nanoparticles. Nanoparticles were injected into mice (normal and athymic) either in the tail vein or into the peritoneum. CONCLUSION: Neutral and zwitterionic nanoparticles demonstrated longer circulation time via both i.p. and i.v. administration, whereas negatively and positively charged nanoparticles possessed relatively short half-lives. These pharmacological characteristics were reflected on the tumor uptake and biodistribution of the respective nanoparticles, with enhanced tumor uptake by neutral and zwitterionic nanoparticles via passive targeting.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0024374

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Structural representation of gold nanoparticles (2 nm core diameter) used. Gold nanoparticles (AuNPs) of different surface charges were generated by chemical modification of the terminal portion of the ligand bonded to the nanoparticle core. Four types of AuNPs were used neutral (TEGOH), positive (TTMA), negative (TCOOH) and zwitterionic (TZwit). The surface charge was measured by zeta potential.
Figure 1 Structural representation of gold nanoparticles (2 nm core diameter) used. Gold nanoparticles (AuNPs) of different surface charges were generated by chemical modification of the terminal portion of the ligand bonded to the nanoparticle core. Four types of AuNPs were used neutral (TEGOH), positive (TTMA), negative (TCOOH) and zwitterionic (TZwit). The surface charge was measured by zeta potential.CC BY · PubMed Central
Figure 2 Plasma profiles for gold nanoparticles. Normal mice were injected either (A) intravenously or (B) intraperitoneally. Data points are the mean +/− SEM from n = 3 animals.
Figure 2 Plasma profiles for gold nanoparticles. Normal mice were injected either (A) intravenously or (B) intraperitoneally. Data points are the mean +/− SEM from n = 3 animals.CC BY · PubMed Central
Figure 3 Quantification of in vivo accumulation of gold nanoparticles into tumors. Coinciding with the blood concentration, nanoparticles that showed a long retention time in circulation were able to extravasate and accumulate into the tumor. Data points are the mean +/− SEM from n = 5 animals.
Figure 3 Quantification of in vivo accumulation of gold nanoparticles into tumors. Coinciding with the blood concentration, nanoparticles that showed a long retention time in circulation were able to extravasate and accumulate into the tumor. Data points are the mean +/− SEM from n = 5 animals.CC BY · PubMed Central
Figure 4 Tissue distribution of gold nanoparticles in mice. In vivo mean gold concentration (µg) per gram of organ 24 hours post (A) IP injection and (B) IV injection. The mode of administration and the ligand end group of AuNPs affects the level of gold uptake in different tissues with the RES being the dominant mode of clearance. Data points are the mean +/− SEM from n = 5 animals. Results are reported as gold concentration (µg) per gram of organ.
Figure 4 Tissue distribution of gold nanoparticles in mice. In vivo mean gold concentration (µg) per gram of organ 24 hours post (A) IP injection and (B) IV injection. The mode of administration and the ligand end group of AuNPs affects the level of gold uptake in different tissues with the RES being the dominant mode of clearance. Data points are the mean +/− SEM from n = 5 animals. Results are reported as gold concentration (µg) per gram of organ.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Arvizo, R. R., Miranda, O. R., Moyano, D. F., Walden, C. A., Giri, K., Bhattacharya, R., Robertson, J. D., Rotello, V. M., Reid, J. M., & Mukherjee, P.
Affiliations
  • Mayo Clinic (US)
  • University of Massachusetts Amherst (US)
  • University of Missouri (US)
Corresponding author
Mukherjee, Priyabrata
ORCID
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2011-09-13
Volume
6
Issue
9
Pages
e24374
ISSN
1932-6203 (ISSN-L)
DOI
10.1371/journal.pone.0024374
PMC
PMC3172229
OpenAlex
W2053311966
Cited by
403
References
43
Citations by year
2026: 11 · 2025: 25 · 2024: 25 · 2023: 27 · 2022: 27 · 2021: 36 · 2020: 37 · 2019: 41 · 2018: 23 · 2017: 34 · 2016: 30 · 2015: 24 · 2014: 21 · 2013: 27 · 2012: 11
FWCI
8.13
Type
journal article
Language
en
Open access
Licence
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institutes of Health (GM077173)
  • National Cancer Institute (R01CA136494, CA135001, CA136494)
  • National Institute of General Medical Sciences (GM-077173, R01GM077173)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
Keywords
engineered nanoparticles, surface charge, surface chemistry, pharmacokinetics, tumor uptake, tissue distribution, circulation time, zwitterionic nanoparticles, passive targeting, nanoparticle clearance, nude mice, intraperitoneal injection, intravenous injection
MeSH terms
Animals, Gold, Ligands, Male, Neoplasms, Surface Properties, Time Factors, Tissue Distribution, Nanotechnology, Cell Line, Tumor, Mice, Metal Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review